Browsing by Author Ganotakis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date???itemlist.???
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and womenAthyros, V. G.; Ganotakis, E.; Kolovou, G. D.; Nicolaou, V.; Achimastos, A.; Bilianou, E.; Alexandrides, T.; Karagiannis, A.; Paletas, K.; Liberopoulos, E. N.; Tziomalos, K.; Petridis, D.; Kakafika, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndromeChimonas, T.; Athyros, V. G.; Ganotakis, E.; Nicolaou, V.; Panagiotakos, D. B.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot studyRizos, E.; Bairaktari, E.; Kostoula, A.; Hasiotis, G.; Achimastos, A.; Ganotakis, E.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymesRizos, E.; Bairaktari, E.; Ganotakis, E.; Tsimihodimos, V.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of various fibrates on serum alkaline phosphatase activityGanotakis, E.; Tsimihodimos, V.; Bairaktari, E.; Rizos, E.; Athyros, V. G.; Seferiades, C.; Elisaf, M. S.24-Nov-2015-
Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT AnalysisAthyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015-